Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis | Zendy

Helen Defty | Zendy; Edward Sames | Zendy; Teresa Doherty | Zendy; Rodney Hughes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis

Author(s) -

Helen Defty,

Edward Sames,

Teresa Doherty,

Rodney Hughes

Publication year - 2013

Publication title -

case reports in rheumatology

Language(s) - English

Resource type - Journals

eISSN - 2090-6889

pISSN - 2090-6897

DOI - 10.1155/2013/728371

Subject(s) - etanercept , medicine , rheumatoid arthritis , transverse myelitis , methotrexate , myelitis , tumor necrosis factor alpha , acute transverse myelitis , infliximab , dermatology , surgery , immunology , multiple sclerosis , spinal cord , psychiatry

Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research